pubmed-article:18483388 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C0948216 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C0178719 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C0007745 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C0013203 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C0032521 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C1999177 | lld:lifeskim |
pubmed-article:18483388 | lifeskim:mentions | umls-concept:C1450054 | lld:lifeskim |
pubmed-article:18483388 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:18483388 | pubmed:dateCreated | 2008-5-16 | lld:pubmed |
pubmed-article:18483388 | pubmed:abstractText | To modulate intracellular ceramide levels and lower the apoptotic threshold in multidrug-resistant ovarian adenocarcinoma, we have examined the efficacy and preliminary safety of tamoxifen coadministration with paclitaxel in biodegradable poly(ethylene oxide)-modified poly(epsilon-caprolactone) (PEO-PCL) nanoparticles. | lld:pubmed |
pubmed-article:18483388 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:language | eng | lld:pubmed |
pubmed-article:18483388 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18483388 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18483388 | pubmed:month | May | lld:pubmed |
pubmed-article:18483388 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:18483388 | pubmed:author | pubmed-author:SeidenMichael... | lld:pubmed |
pubmed-article:18483388 | pubmed:author | pubmed-author:AmijiMansoor... | lld:pubmed |
pubmed-article:18483388 | pubmed:author | pubmed-author:DuanZhenfengZ | lld:pubmed |
pubmed-article:18483388 | pubmed:author | pubmed-author:DevalapallyHa... | lld:pubmed |
pubmed-article:18483388 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:18483388 | pubmed:day | 15 | lld:pubmed |
pubmed-article:18483388 | pubmed:volume | 14 | lld:pubmed |
pubmed-article:18483388 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18483388 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18483388 | pubmed:pagination | 3193-203 | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:meshHeading | pubmed-meshheading:18483388... | lld:pubmed |
pubmed-article:18483388 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18483388 | pubmed:articleTitle | Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles. | lld:pubmed |
pubmed-article:18483388 | pubmed:affiliation | Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA 02115, USA. | lld:pubmed |
pubmed-article:18483388 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18483388 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483388 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18483388 | lld:pubmed |